{"transactions":[{"id":691388,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24809,"kind":"person","name":"FELDMAN FREDRIC J","position":1,"cik":"0001191704","reported_name":"FELDMAN FREDRIC J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:21:57.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":105124,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 95,000 and 105,124 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":200124,"source":{"system":"sec-edgar","filing":"0001437749-26-027123","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027123/rdgdoc.xml","form_type":"4"}},{"id":691387,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24809,"kind":"person","name":"FELDMAN FREDRIC J","position":1,"cik":"0001191704","reported_name":"FELDMAN FREDRIC J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:21:57.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":95000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 95,000 and 105,124 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001437749-26-027123","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027123/rdgdoc.xml","form_type":"4"}},{"id":691385,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24807,"kind":"person","name":"Grotke Kevin Allan","position":1,"cik":"0002146532","reported_name":"Grotke Kevin Allan","relationship":{"officer":true,"officer_title":"President & CEO of TotalStone"}}],"security":"Common Stock","published_at":"2026-08-12T00:21:29.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":515495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 515,495 shares of common stock granted to the Reporting Person on August 7, 2026 as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full on August 7, 2029, the third anniversary of the grant date, subject to the Reporting Person's continued service."}],"balance_after":1041597,"source":{"system":"sec-edgar","filing":"0001437749-26-027122","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027122/rdgdoc.xml","form_type":"4"}},{"id":691384,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24806,"kind":"person","name":"HOLLIMAN JOHN M III","position":1,"cik":"0000938112","reported_name":"HOLLIMAN JOHN M III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:21:01.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":305248,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 95,000 and 305,248 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":401343,"source":{"system":"sec-edgar","filing":"0001437749-26-027121","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027121/rdgdoc.xml","form_type":"4"}},{"id":691383,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24806,"kind":"person","name":"HOLLIMAN JOHN M III","position":1,"cik":"0000938112","reported_name":"HOLLIMAN JOHN M III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:21:01.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":95000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 95,000 and 305,248 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001437749-26-027121","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027121/rdgdoc.xml","form_type":"4"}},{"id":691382,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24805,"kind":"person","name":"HOWSE ELWOOD D","position":1,"cik":"0001191706","reported_name":"HOWSE ELWOOD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:20:34.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":105124,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 95,000 and 105,124 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":200124,"source":{"system":"sec-edgar","filing":"0001437749-26-027120","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027120/rdgdoc.xml","form_type":"4"}},{"id":691381,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24805,"kind":"person","name":"HOWSE ELWOOD D","position":1,"cik":"0001191706","reported_name":"HOWSE ELWOOD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:20:34.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":95000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 95,000 and 105,124 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001437749-26-027120","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027120/rdgdoc.xml","form_type":"4"}},{"id":691380,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24804,"kind":"person","name":"Lipman Matthew E.","position":1,"cik":"0001687758","reported_name":"Lipman Matthew E.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-12T00:20:05.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":1094648,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 1,094,648 shares of common stock granted to the Reporting Person on August 7, 2026 as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full on August 7, 2029, the third anniversary of the grant date, subject to the Reporting Person's continued service."}],"balance_after":1492648,"source":{"system":"sec-edgar","filing":"0001437749-26-027119","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027119/rdgdoc.xml","form_type":"4"}},{"id":691379,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24803,"kind":"person","name":"SCHULTZ EDWARD CHRISTOPHER","position":1,"cik":"0002065236","reported_name":"SCHULTZ EDWARD CHRISTOPHER","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T00:19:34.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":310310,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 310,310 shares of common stock granted to the Reporting Person on August 7, 2026 as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full on August 7, 2029, the third anniversary of the grant date, subject to the Reporting Person's continued service."}],"balance_after":500310,"source":{"system":"sec-edgar","filing":"0001437749-26-027118","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027118/rdgdoc.xml","form_type":"4"}},{"id":691377,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24801,"kind":"person","name":"Strout Gordon Lewis Jr","position":1,"cik":"0002128514","reported_name":"Strout Gordon Lewis Jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:19:08.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":357810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 142,500 and 357,810 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":541810,"source":{"system":"sec-edgar","filing":"0001437749-26-027117","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027117/rdgdoc.xml","form_type":"4"}},{"id":691376,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24801,"kind":"person","name":"Strout Gordon Lewis Jr","position":1,"cik":"0002128514","reported_name":"Strout Gordon Lewis Jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:19:08.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":142500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 142,500 and 357,810 shares of common stock granted to the Reporting Person on March 30, 2026 and August 7, 2026, respectively, as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":184000,"source":{"system":"sec-edgar","filing":"0001437749-26-027117","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027117/rdgdoc.xml","form_type":"4"}},{"id":691375,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24801,"kind":"person","name":"Strout Gordon Lewis Jr","position":1,"cik":"0002128514","reported_name":"Strout Gordon Lewis Jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:19:08.000Z","date":"2025-03-07","kind":"purchase","planned":false,"acquired":true,"shares":41500,"price":4,"value":166000.0,"ownership":{"direct":true},"balance_after":41500,"source":{"system":"sec-edgar","filing":"0001437749-26-027117","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027117/rdgdoc.xml","form_type":"4"}},{"id":691374,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24801,"kind":"person","name":"Strout Gordon Lewis Jr","position":1,"cik":"0002128514","reported_name":"Strout Gordon Lewis Jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:19:08.000Z","date":"2025-03-07","kind":"other","planned":false,"acquired":true,"shares":822128,"ownership":{"direct":false,"nature":"By Gordon Rocks, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 7, 2025, pursuant to a Master Exchange Agreement entered into among the Issuer, its operating subsidiary, TotalStone, LLC (\"TotalStone\"), and TotalStone's Class B and Class C Members, all of the Preferred Interests in TotalStone previously owned by the Reporting Person were exchanged for 822,128 shares of the Issuer's Common Stock."}],"balance_after":822128,"source":{"system":"sec-edgar","filing":"0001437749-26-027117","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027117/rdgdoc.xml","form_type":"4"}},{"id":691378,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24802,"kind":"person","name":"TOPOREK MICHAEL","position":1,"cik":"0001243628","reported_name":"TOPOREK MICHAEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-12T00:18:35.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":1094647,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 1,094,647 shares of common stock granted to the Reporting Person on August 7, 2026 as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement."}],"balance_after":1492647,"source":{"system":"sec-edgar","filing":"0001437749-26-027116","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926027116/rdgdoc.xml","form_type":"4"}},{"id":703693,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24802,"kind":"person","name":"TOPOREK MICHAEL","position":1,"cik":"0001243628","reported_name":"TOPOREK MICHAEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-24T20:28:28.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":356250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A is being filed solely to correct the nature of the shares and the vesting schedule reported as granted on April 1, 2026. This amendment reflects that the shares granted were shares of common stock, rather than restricted stock units, and corrects the vesting schedule of the shares granted."},{"field":"shares","element":"transactionShares","label":"F2","text":"Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards will vest in full only upon the Reporting Person's death or disability, removal from the Board of Directors other than for Cause, or failure to be re-elected to the Board of Directors. If the Reporting Person voluntarily resigns from the Board of Directors before the applicable vesting event, the restricted stock awards will be forfeited."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards will vest in full only upon the Reporting Person's death or disability, removal from the Board of Directors other than for Cause, or failure to be re-elected to the Board of Directors. If the Reporting Person voluntarily resigns from the Board of Directors before the applicable vesting event, the restricted stock awards will be forfeited."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards will vest in full only upon the Reporting Person's death or disability, removal from the Board of Directors other than for Cause, or failure to be re-elected to the Board of Directors. If the Reporting Person voluntarily resigns from the Board of Directors before the applicable vesting event, the restricted stock awards will be forfeited."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes 121,774 shares controlled by the Reporting Person, through his control of BP Peptides, LLC."}],"balance_after":391678,"source":{"system":"sec-edgar","filing":"0001437749-26-024418","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926024418/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-04-01"}},{"id":703692,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24802,"kind":"person","name":"TOPOREK MICHAEL","position":1,"cik":"0001243628","reported_name":"TOPOREK MICHAEL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-24T20:27:59.000Z","date":"2025-03-07","kind":"purchase","planned":false,"acquired":true,"shares":41750,"price":4,"value":167000.0,"ownership":{"direct":true},"balance_after":41750,"source":{"system":"sec-edgar","filing":"0001437749-26-024417","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926024417/rdgdoc.xml","form_type":"4"}},{"id":704982,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24804,"kind":"person","name":"Lipman Matthew E.","position":1,"cik":"0001687758","reported_name":"Lipman Matthew E.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-23T01:12:06.000Z","date":"2025-03-07","kind":"purchase","planned":false,"acquired":true,"shares":41750,"price":4,"value":167000.0,"ownership":{"direct":true},"balance_after":2570412,"source":{"system":"sec-edgar","filing":"0001437749-26-024215","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926024215/rdgdoc.xml","form_type":"4"}},{"id":704981,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24804,"kind":"person","name":"Lipman Matthew E.","position":1,"cik":"0001687758","reported_name":"Lipman Matthew E.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-23T01:11:40.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":356250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A is being filed solely to correct the nature of the shares reported as granted on April 1, 2026. This amendment reflects that the shares granted were shares of common stock, rather than restricted stock units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Excludes 121,774 shares controlled by the Reporting Person, through his control of BP Peptides, LLC."}],"balance_after":2920340,"source":{"system":"sec-edgar","filing":"0001437749-26-024214","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926024214/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-04-01"}},{"id":704980,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24803,"kind":"person","name":"SCHULTZ EDWARD CHRISTOPHER","position":1,"cik":"0002065236","reported_name":"SCHULTZ EDWARD CHRISTOPHER","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-23T01:11:11.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":190000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A is being filed solely to correct the nature of the shares reported as granted on April 1, 2026. This amendment reflects that the shares granted were shares of common stock, rather than restricted stock units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Including 190,000 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Including 190,000 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including 190,000 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":190000,"source":{"system":"sec-edgar","filing":"0001437749-26-024213","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000143774926024213/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-04-01"}},{"id":823543,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24803,"kind":"person","name":"SCHULTZ EDWARD CHRISTOPHER","position":1,"cik":"0002065236","reported_name":"SCHULTZ EDWARD CHRISTOPHER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Award","published_at":"2026-04-01T22:42:32.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0.649,"value":123310.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":190000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001213900-26-038703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000121390026038703/ownership.xml","form_type":"4"}},{"id":823542,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24804,"kind":"person","name":"Lipman Matthew E.","position":1,"cik":"0001687758","reported_name":"Lipman Matthew E.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Award","published_at":"2026-04-01T22:41:21.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":356250,"price":0.649,"value":231206.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":356250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":356250},"source":{"system":"sec-edgar","filing":"0001213900-26-038702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000121390026038702/ownership.xml","form_type":"4"}},{"id":823541,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24802,"kind":"person","name":"TOPOREK MICHAEL","position":1,"cik":"0001243628","reported_name":"TOPOREK MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2026-04-01T22:40:16.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":356250,"price":0.649,"value":231206.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The RSUs vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":356250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":356250},"source":{"system":"sec-edgar","filing":"0001213900-26-038701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000121390026038701/ownership.xml","form_type":"4"}},{"id":3717073,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":18689,"kind":"person","name":"SUBIN NEIL S","position":1,"cik":"0001201333","reported_name":"SUBIN NEIL S","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T17:36:19.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":103000,"price":0.052,"value":5356.0,"ownership":{"direct":false,"nature":"By LIMFAM LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved a sale of a total of 206,000 shares of Capstone Therapeutics Corp. (\"Capstone\") common stock by MBM -\nTrust A-4, which were acquired by LIMFAM LLC and another private purchaser at a privately negotiated price equal to $0.052 per share. The reporting person\nmay be deemed to have voting and dispositive control over shares held by MBM - Trust A-4 and LIMFAM LLC."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person believes that the reported transaction constitutes a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Act pursuant to Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Except for possessing voting and dispositive power, the reporting person disclaims any other beneficial ownership of, and specifically any pecuniary interest in, the securities reported herein. This filing is not, and shall not be deemed, an admission (and the reporting person expressly disclaims) that the reporting person is, for purposes of Rule 16a-1(a)(2) under Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any equity securities covered by this filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person succeeded to the position of President and Manager of MILFAM LLC, which serves as manager, general partner, or investment advisor of a number of entities formerly managed or advised by the late Lloyd I. Miller, III.  The reporting person also serves as trustee of a number of Miller family trusts."}],"balance_after":727100,"source":{"system":"sec-edgar","filing":"0001209191-18-064285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887151/000120919118064285/doc4.xml","form_type":"4"}},{"id":3717072,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":18689,"kind":"person","name":"SUBIN NEIL S","position":1,"cik":"0001201333","reported_name":"SUBIN NEIL S","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T17:36:19.000Z","date":"2018-12-21","kind":"sale","acquired":false,"shares":206000,"price":0.052,"value":10712.0,"ownership":{"direct":false,"nature":"By MBM - Trust A-4"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved a sale of a total of 206,000 shares of Capstone Therapeutics Corp. (\"Capstone\") common stock by MBM -\nTrust A-4, which were acquired by LIMFAM LLC and another private purchaser at a privately negotiated price equal to $0.052 per share. The reporting person\nmay be deemed to have voting and dispositive control over shares held by MBM - Trust A-4 and LIMFAM LLC."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person believes that the reported transaction constitutes a change in the form of beneficial ownership without changing the reporting person's pecuniary interest in such securities and was exempt from Section 16 of the Act pursuant to Rule 16a-13."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Except for possessing voting and dispositive power, the reporting person disclaims any other beneficial ownership of, and specifically any pecuniary interest in, the securities reported herein. This filing is not, and shall not be deemed, an admission (and the reporting person expressly disclaims) that the reporting person is, for purposes of Rule 16a-1(a)(2) under Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any equity securities covered by this filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person succeeded to the position of President and Manager of MILFAM LLC, which serves as manager, general partner, or investment advisor of a number of entities formerly managed or advised by the late Lloyd I. Miller, III.  The reporting person also serves as trustee of a number of Miller family trusts."}],"balance_after":2708484,"source":{"system":"sec-edgar","filing":"0001209191-18-064285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000120919118064285/doc4.xml","form_type":"4"}},{"id":4082500,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24804,"kind":"person","name":"Lipman Matthew E.","position":1,"cik":"0001687758","reported_name":"Lipman Matthew E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":169924,"kind":"person","name":"BP Peptides, LLC","position":2,"cik":"0001711689","reported_name":"BP Peptides, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2018-02-01T23:00:35.000Z","date":"2018-01-30","kind":"other","acquired":true,"shares":1,"ownership":{"direct":false,"nature":"By: BP Peptides, LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by BP Peptides, LLC (\"BP Peptides\") and Matthew E. Lipman (collectively, the \"Reporting Persons\"). Mr. Lipman is a director of the Issuer. BP Peptides may be deemed to be a director by deputization by virtue of the fact that Mr. Lipman, the Manager and President of BP Peptides, is a director of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The Warrant was issued by the Issuer to BP Peptides in consideration of BP Peptides' agreement to defer all accrued but unpaid interest due under its loan to the Issuer until October 15, 2020 (the \"Maturity Date\").  The Warrant vests quarterly in accordance with Schedule 1 thereto and will be fully vested on the Maturity Date; provided, however, that in the event of a Deferred Interest Repayment (as defined in the Warrant), then all vesting shall immediately terminate and lapse as to any Warrant shares that have not yet vested and none of such Warrant shares shall become vested.  In no event may the Warrant be exercised if and to the extent that such exercise would be inconsistent with or constitute a violation of the Issuer's Tax Benefit Preservation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Warrant was issued by the Issuer to BP Peptides in consideration of BP Peptides' agreement to defer all accrued but unpaid interest due under its loan to the Issuer until October 15, 2020 (the \"Maturity Date\").  The Warrant vests quarterly in accordance with Schedule 1 thereto and will be fully vested on the Maturity Date; provided, however, that in the event of a Deferred Interest Repayment (as defined in the Warrant), then all vesting shall immediately terminate and lapse as to any Warrant shares that have not yet vested and none of such Warrant shares shall become vested.  In no event may the Warrant be exercised if and to the extent that such exercise would be inconsistent with or constitute a violation of the Issuer's Tax Benefit Preservation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Warrant was issued by the Issuer to BP Peptides in consideration of BP Peptides' agreement to defer all accrued but unpaid interest due under its loan to the Issuer until October 15, 2020 (the \"Maturity Date\").  The Warrant vests quarterly in accordance with Schedule 1 thereto and will be fully vested on the Maturity Date; provided, however, that in the event of a Deferred Interest Repayment (as defined in the Warrant), then all vesting shall immediately terminate and lapse as to any Warrant shares that have not yet vested and none of such Warrant shares shall become vested.  In no event may the Warrant be exercised if and to the extent that such exercise would be inconsistent with or constitute a violation of the Issuer's Tax Benefit Preservation Plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities owned directly by BP Peptides. As the Manager and President of BP Peptides, Mr. Lipman may be deemed to beneficially own the securities owned directly by BP Peptides. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein."}],"balance_after":1,"derivative":{"exercise_price":0.075,"expiration_date":"2025-10-15","underlying":"Common Stock, $0.0005 par value","underlying_shares":6321930},"source":{"system":"sec-edgar","filing":"0000921895-18-000366","document":"form410959006_02012018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887151/000092189518000366/form410959006_02012018.xml","form_type":"4"}},{"id":4189528,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":170765,"kind":"person","name":"MILLER LLOYD I III","position":1,"cik":"0000949119","reported_name":"MILLER LLOYD I III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T19:00:01.000Z","date":"2017-10-05","kind":"sale","acquired":false,"shares":100000,"price":0.06,"value":6000.0,"ownership":{"direct":false,"nature":"By LIMFAM LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.  This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing."}],"balance_after":624100,"source":{"system":"sec-edgar","filing":"0001209191-17-056389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000120919117056389/doc4.xml","form_type":"4"}},{"id":4255656,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":30208,"kind":"organization","name":"BVF PARTNERS L P/IL","position":1,"cik":"0001055947","reported_name":"BVF PARTNERS L P/IL","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30209,"kind":"organization","name":"BIOTECHNOLOGY VALUE FUND L P","position":2,"cik":"0000918923","reported_name":"BIOTECHNOLOGY VALUE FUND L P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30211,"kind":"organization","name":"BIOTECHNOLOGY VALUE FUND II LP","position":3,"cik":"0001102444","reported_name":"BIOTECHNOLOGY VALUE FUND II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":174373,"kind":"organization","name":"BVF INVESTMENTS LLC","position":4,"cik":"0001132245","reported_name":"BVF INVESTMENTS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30216,"kind":"organization","name":"BVF INC/IL","position":5,"cik":"0001056807","reported_name":"BVF INC/IL","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30217,"kind":"person","name":"LAMPERT MARK N","position":6,"cik":"0001233840","reported_name":"LAMPERT MARK N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}}],"security":"Common Stock, $0.0005 par value","published_at":"2017-07-18T23:59:00.000Z","date":"2017-07-14","kind":"sale","acquired":false,"shares":105713,"price":0.06,"value":6342.78,"ownership":{"direct":false,"nature":"By Biotechnology Value Fund II, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Biotechnology Value Fund, L.P. (\"BVF\"), Biotechnology Value Fund II, L.P. (\"BVF2\"), BVF Investments, L.L.C. (\"BVFLLC\"), BVF Partners L.P. (\"Partners\"), BVF Inc., and Mark Lampert (collectively the \"Reporting Persons\"). Each of the Reporting Persons is a member of a Section 13G group that no longer owns more than 10% of the Issuer's outstanding shares of Common Stock pursuant to Rule 16a-1(a)(1). Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein."},{"field":"kind","element":"transactionCoding","label":"F6","text":"On the Transaction Date, the Reporting Persons entered into and consummated a private sale with an entity that is unaffiliated with the Reporting Persons."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares of Common Stock owned directly by BVF2. As the general partner of BVF2, Partners may be deemed to beneficially own the shares of Common Stock owned directly by BVF2. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the shares of Common Stock owned directly by BVF2. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the shares of Common Stock owned directly by BVF2."}],"balance_after":890487,"source":{"system":"sec-edgar","filing":"0000921895-17-001936","document":"form407422010_07182017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/887151/000092189517001936/form407422010_07182017.xml","form_type":"4"}},{"id":4255655,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":30208,"kind":"organization","name":"BVF PARTNERS L P/IL","position":1,"cik":"0001055947","reported_name":"BVF PARTNERS L P/IL","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30209,"kind":"organization","name":"BIOTECHNOLOGY VALUE FUND L P","position":2,"cik":"0000918923","reported_name":"BIOTECHNOLOGY VALUE FUND L P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30211,"kind":"organization","name":"BIOTECHNOLOGY VALUE FUND II LP","position":3,"cik":"0001102444","reported_name":"BIOTECHNOLOGY VALUE FUND II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":174373,"kind":"organization","name":"BVF INVESTMENTS LLC","position":4,"cik":"0001132245","reported_name":"BVF INVESTMENTS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30216,"kind":"organization","name":"BVF INC/IL","position":5,"cik":"0001056807","reported_name":"BVF INC/IL","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30217,"kind":"person","name":"LAMPERT MARK N","position":6,"cik":"0001233840","reported_name":"LAMPERT MARK N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}}],"security":"Common Stock, $0.0005 par value","published_at":"2017-07-18T23:59:00.000Z","date":"2017-07-14","kind":"sale","acquired":false,"shares":242236,"price":0.06,"value":14534.16,"ownership":{"direct":false,"nature":"By Biotechnology Value Fund, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Biotechnology Value Fund, L.P. (\"BVF\"), Biotechnology Value Fund II, L.P. (\"BVF2\"), BVF Investments, L.L.C. (\"BVFLLC\"), BVF Partners L.P. (\"Partners\"), BVF Inc., and Mark Lampert (collectively the \"Reporting Persons\"). Each of the Reporting Persons is a member of a Section 13G group that no longer owns more than 10% of the Issuer's outstanding shares of Common Stock pursuant to Rule 16a-1(a)(1). Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein."},{"field":"kind","element":"transactionCoding","label":"F6","text":"On the Transaction Date, the Reporting Persons entered into and consummated a private sale with an entity that is unaffiliated with the Reporting Persons."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Shares of Common Stock owned directly by BVF. As the general partner of BVF, Partners may be deemed to beneficially own the shares of Common Stock owned directly by BVF. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the shares of Common Stock owned directly by BVF. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the shares of Common Stock owned directly by BVF."}],"balance_after":1377652,"source":{"system":"sec-edgar","filing":"0000921895-17-001936","document":"form407422010_07182017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/887151/000092189517001936/form407422010_07182017.xml","form_type":"4"}},{"id":4255654,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":30208,"kind":"organization","name":"BVF PARTNERS L P/IL","position":1,"cik":"0001055947","reported_name":"BVF PARTNERS L P/IL","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30209,"kind":"organization","name":"BIOTECHNOLOGY VALUE FUND L P","position":2,"cik":"0000918923","reported_name":"BIOTECHNOLOGY VALUE FUND L P","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30211,"kind":"organization","name":"BIOTECHNOLOGY VALUE FUND II LP","position":3,"cik":"0001102444","reported_name":"BIOTECHNOLOGY VALUE FUND II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":174373,"kind":"organization","name":"BVF INVESTMENTS LLC","position":4,"cik":"0001132245","reported_name":"BVF INVESTMENTS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30216,"kind":"organization","name":"BVF INC/IL","position":5,"cik":"0001056807","reported_name":"BVF INC/IL","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}},{"id":30217,"kind":"person","name":"LAMPERT MARK N","position":6,"cik":"0001233840","reported_name":"LAMPERT MARK N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Explanation of Responses"}}],"security":"Common Stock, $0.0005 par value","published_at":"2017-07-18T23:59:00.000Z","date":"2017-07-14","kind":"sale","acquired":false,"shares":3993637,"price":0.06,"value":239618.22,"ownership":{"direct":false,"nature":"By BVF Investments, L.L.C."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is filed jointly by Biotechnology Value Fund, L.P. (\"BVF\"), Biotechnology Value Fund II, L.P. (\"BVF2\"), BVF Investments, L.L.C. (\"BVFLLC\"), BVF Partners L.P. (\"Partners\"), BVF Inc., and Mark Lampert (collectively the \"Reporting Persons\"). Each of the Reporting Persons is a member of a Section 13G group that no longer owns more than 10% of the Issuer's outstanding shares of Common Stock pursuant to Rule 16a-1(a)(1). Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein."},{"field":"kind","element":"transactionCoding","label":"F6","text":"On the Transaction Date, the Reporting Persons entered into and consummated a private sale with an entity that is unaffiliated with the Reporting Persons."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares of Common Stock owned directly by BVFLLC. As the manager of BVFLLC, Partners may be deemed to beneficially own the shares of Common Stock owned directly by BVFLLC. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the shares of Common Stock owned directly by BVFLLC. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the shares of Common Stock owned directly by BVFLLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Pursuant to the operating agreement of BVFLLC, Partners is authorized, among other things, to invest the contributed capital of Samana Capital, L.P., the majority member of BVFLLC, in the Common Stock and other securities of the Issuer and to vote, exercise or convert and dispose of such securities and is entitled to receive fees based on assets under management and, subject to certain exceptions, allocations based on realized and unrealized gains on such assets."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000921895-17-001936","document":"form407422010_07182017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000092189517001936/form407422010_07182017.xml","form_type":"4"}},{"id":4496974,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":179847,"kind":"person","name":"TAEGER LESLIE M","position":1,"cik":"0001257174","reported_name":"TAEGER LESLIE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-01-06T22:00:17.000Z","date":"2017-01-04","kind":"purchase","acquired":true,"shares":50000,"price":0.07,"value":3500.0,"ownership":{"direct":true},"balance_after":94574,"source":{"system":"sec-edgar","filing":"0001171843-17-000130","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000117184317000130/formfour.xml","form_type":"4"}},{"id":4517627,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":170765,"kind":"person","name":"MILLER LLOYD I III","position":1,"cik":"0000949119","reported_name":"MILLER LLOYD I III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T19:30:37.000Z","date":"2016-12-16","kind":"sale","acquired":false,"shares":38967,"price":0.04,"value":1558.68,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-155829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000120919116155829/doc4.xml","form_type":"4"}},{"id":4519561,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":170765,"kind":"person","name":"MILLER LLOYD I III","position":1,"cik":"0000949119","reported_name":"MILLER LLOYD I III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T19:14:10.000Z","date":"2016-12-15","kind":"sale","acquired":false,"shares":20000,"price":0.04,"value":800.0,"ownership":{"direct":true},"balance_after":38967,"source":{"system":"sec-edgar","filing":"0001209191-16-155593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000120919116155593/doc4.xml","form_type":"4"}},{"id":4559060,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24805,"kind":"person","name":"HOWSE ELWOOD D","position":1,"cik":"0001191706","reported_name":"HOWSE ELWOOD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-14T16:47:38.000Z","date":"2016-11-10","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":421500,"derivative":{"exercise_price":0.05,"exercise_date":"2016-11-10","expiration_date":"2026-11-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-16-013194","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000117184316013194/formfour.xml","form_type":"4"}},{"id":4559059,"issuer":{"id":8383,"kind":"organization","name":"Capstone Holding Corp."},"owners":[{"id":24809,"kind":"person","name":"FELDMAN FREDRIC J","position":1,"cik":"0001191704","reported_name":"FELDMAN FREDRIC J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-11-14T16:47:10.000Z","date":"2016-11-10","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":421500,"derivative":{"exercise_price":0.05,"exercise_date":"2016-11-10","expiration_date":"2026-11-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001171843-16-013193","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/887151/000117184316013193/formfour.xml","form_type":"4"}}]}